Literature DB >> 10073717

The serum albumin-binding region of streptococcal protein G (BB) potentiates the immunogenicity of the G130-230 RSV-A protein.

C Libon1, N Corvaïa, J F Haeuw, T N Nguyen, S Ståhl, J Y Bonnefoy, C Andreoni.   

Abstract

BBG2Na is a protein comprising residues 130-230 of the respiratory syncytial virus subgroup A (RSV-A) G protein (G2Na) fused to the albumin-binding domain of streptococcal G protein (BB). BBG2Na was cloned, expressed in Escherichia coli and renaturated. In rodent models, this subunit RSV vaccine adjuvanted in Alhydrogel induced specific antibodies and conferred protection to RSV infection. Comparison of the antibody production in a BALB/c mouse model revealed that BBG2Na induced a stronger and earlier G2Na antibody response than G2Na alone, without altering the IgG subclass distribution. To address the role of the BB part, we explored its carrier properties and showed that it is a Th dependent antigen, generating a more potent G2Na-specific B cell memory response and able to generate Th cells that provide help for G2Na antibody production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073717     DOI: 10.1016/s0264-410x(98)00198-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Mutational analysis of the interaction between albumin-binding domain from streptococcal protein G and human serum albumin.

Authors:  Martin Linhult; Hans Kaspar Binz; Mathias Uhlén; Sophia Hober
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

2.  Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.

Authors:  Helene Plotnicky-Gilquin; Dominique Cyblat-Chanal; Jean-Pierre Aubry; Thierry Champion; Alain Beck; Thien Nguyen; Jean-Yves Bonnefoy; Nathalie Corvaïa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 3.  Recent trends in protein and peptide-based biomaterials for advanced drug delivery.

Authors:  Anastasia Varanko; Soumen Saha; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2020-08-29       Impact factor: 15.470

4.  Site-specific fatty acid-conjugation to prolong protein half-life in vivo.

Authors:  Sung In Lim; Yukina Mizuta; Akinori Takasu; Young S Hahn; Yong Hwan Kim; Inchan Kwon
Journal:  J Control Release       Date:  2013-06-02       Impact factor: 9.776

Review 5.  Harnessing albumin as a carrier for cancer therapies.

Authors:  Ella N Hoogenboezem; Craig L Duvall
Journal:  Adv Drug Deliv Rev       Date:  2018-07-27       Impact factor: 15.470

6.  The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents.

Authors:  Thien N Nguyen; Ultan F Power; Alain Robert; Jean-François Haeuw; Katia Helffer; Amadeo Perez; Miguel-Angel Asin; Nathalie Corvaia; Christine Libon
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

7.  Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148.

Authors:  Liliane Goetsch; Jean Francois Haeuw; Thierry Champion; Christine Lacheny; Thien N'Guyen; Alain Beck; Nathalie Corvaia
Journal:  Clin Diagn Lab Immunol       Date:  2003-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.